ICB
0462.541.431 · rovalta.com · 23/09/2026
ICB
Overview
What does ICB do?
ICB is a Private limited company incorporated in 1998. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles. It employs on average 2,0 ETP workers (FTE).
1000 Bruxelles · BruxellesSee on map
Joint committees (3)
- 100
- 200
- 218
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Revenue | 4,7 M € | – | 0 € | 0 € | 0 € | 0 € | 0 € | 0 € | – | – | – | – | – | – | – | – | – | – | – | – | |||||||||||||||||||
| EBITDA | 635,1 k € | +17.5% | 540,6 k € | -2.2% | 552,9 k € | -30.9% | 800,7 k € | +43.1% | 559,6 k € | +23.0% | 454,8 k € | -4.1% | 474,2 k € | +141% | 196,8 k € | -39.2% | 323,9 k € | +2499% | 12,5 k € | -37.2% | 19,8 k € | +15.6% | 17,2 k € | +35.3% | 12,7 k € | +19.3% | 10,6 k € | +566% | 1,6 k € | -75.4% | 6,5 k € | +31.7% | 4,9 k € | +7.4% | 4,6 k € | -22.0% | 5,9 k € | -23.1% | 7,7 k € |
| Operating result | 538,1 k € | +33.5% | 403 k € | -6.8% | 432,6 k € | -38.5% | 703,8 k € | +42.5% | 493,8 k € | +21.3% | 407 k € | -5.6% | 431 k € | +153% | 170,2 k € | -46.7% | 319,6 k € | +2495% | 12,3 k € | +2.4% | 12 k € | +29.8% | 9,3 k € | +18.6% | 7,8 k € | -15.6% | 9,3 k € | +8726% | -107,3 € | -102% | 4,8 k € | +22.5% | 3,9 k € | +9.2% | 3,6 k € | -11.8% | 4,1 k € | -33.5% | 6,1 k € |
| Net result | 307,1 k € | +40.8% | 218 k € | -19.2% | 270 k € | -46.3% | 503 k € | +44.8% | 347,3 k € | +21.7% | 285,3 k € | +5.2% | 271,2 k € | +158% | 105 k € | -49.5% | 207,7 k € | +4560% | 4,5 k € | -45.2% | 8,1 k € | +87.9% | 4,3 k € | +15.4% | 3,7 k € | -9.5% | 4,1 k € | +844% | -557,2 € | -121% | 2,6 k € | +78.7% | 1,5 k € | +45.4% | 1 k € | -52.1% | 2,1 k € | -24.5% | 2,8 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 2 M € | +3.5% | 1,9 M € | +12.9% | 1,7 M € | +19.0% | 1,4 M € | +49.1% | 949,1 k € | +57.7% | 601,9 k € | +90.1% | 316,5 k € | +598% | 45,3 k € | +12.3% | 40,4 k € | +23.8% | 32,6 k € | +15.8% | 28,1 k € | +40.6% | 20 k € | +27.6% | 15,7 k € | +31.4% | 11,9 k € | +53.2% | 7,8 k € | -6.7% | 8,4 k € | +45.9% | 5,7 k € | +34.6% | 4,3 k € | +31.2% | 3,2 k € | +186% | 1,1 k € |
| Total assets | 4,2 M € | -2.5% | 4,3 M € | +18.7% | 3,7 M € | +6.3% | 3,4 M € | +18.7% | 2,9 M € | +16.0% | 2,5 M € | +7.8% | 2,3 M € | +31.4% | 1,8 M € | +33.5% | 1,3 M € | +3111% | 41,2 k € | +10.0% | 37,5 k € | -23.7% | 49,1 k € | +4.3% | 47,1 k € | +42.2% | 33,1 k € | +44.6% | 22,9 k € | +75.5% | 13 k € | -14.5% | 15,3 k € | +8.0% | 14,1 k € | -44.4% | 25,4 k € | -48.6% | 49,4 k € |
| Cash | 693,6 € | -13.8% | 804,7 € | -96.3% | 22 k € | -82.4% | 125,1 k € | +87.4% | 66,7 k € | +1520% | 4,1 k € | +64.8% | 2,5 k € | -67.4% | 7,7 k € | -82.5% | 43,7 k € | +862% | 4,5 k € | +225% | 1,4 k € | -44.2% | 2,5 k € | -59.7% | 6,2 k € | +857% | 647,7 € | -83.8% | 4 k € | +301% | 998,8 € | -38.6% | 1,6 k € | +242% | 475,3 € | +11.0% | 428,4 € | -98.3% | 25,6 k € |
| Debts | 2,3 M € | -6.6% | 2,4 M € | +24.6% | 1,9 M € | -4.0% | 2 M € | +3.9% | 2 M € | +2.8% | 1,9 M € | -5.2% | 2 M € | +16.4% | 1,7 M € | +34.3% | 1,3 M € | +14842% | 8,6 k € | -7.8% | 9,3 k € | -68.0% | 29,1 k € | -4.6% | 30,5 k € | +49.7% | 20,4 k € | +60.3% | 12,7 k € | +171% | 4,7 k € | -50.7% | 9,5 k € | -3.5% | 9,9 k € | -55.5% | 22,2 k € | -54.0% | 48,3 k € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 2,0 ETP | -33.3% | 3,0 ETP | +7.1% | 2,8 ETP | +3.7% | 2,7 ETP | -12.9% | 3,1 ETP | -3.1% | 3,2 ETP | -25.6% | 4,3 ETP | +30.3% | 3,3 ETP | – | – | 2,0 ETP | 0.0% | 2,0 ETP | +53.8% | 1,3 ETP | -35.0% | 2,0 ETP | +100% | 1,0 ETP | +42.9% | 0,7 ETP | – | – | – | – | |||||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 16 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
| 0886.320.375 | |
ASHWELL CONTROLS● Active | 0744.487.965 |
| 0826.311.623 | |
ATLANTIC HOLDING BELGIUM● Liquidation | 0429.408.211 |
AURCELIMMO● Active | 0860.844.811 |
BE BO BUN● Active | 0715.819.220 |
BEMIST● Bankrupt | 0640.878.208 |
BOLESCA● Active | 0659.836.560 |
| 0474.094.032 | |
CABINET DOCTEUR ISABELLE RAHIER● Active | 0820.420.753 |
CHARLOTTE DE CHAFFOY● Active | 0808.914.474 |
Chris Investments Company● Active | 0450.289.044 |
Clinique dentaire des Arts● Active | 0423.183.581 |
C.MEGAMA'S● Active | 0464.399.079 |
Codéveloppement Consulting● Active | 0653.749.217 |
| 0402.084.202 | |
DAMACINE● Liquidation | 0402.891.973 |
D.B. GENERAL CONCEPT● Liquidation | 0875.609.892 |
DEBEUF & CO● Active | 0440.011.695 |
DEVOTA● Active | 0441.144.716 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/07/2026 | 17/06/2025 | 02/07/2024 | 09/08/2023 | 06/07/2022 | 10/06/2021 |
| General meeting | 30/07/2026 | 13/06/2025 | 28/06/2024 | 02/06/2023 | 03/06/2022 | 04/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/07/2026 | 31/07/2026 | French | |
| Abridged model | 31/12/2024 | 13/06/2025 | 17/06/2025 | French | |
| Abridged model | 31/12/2023 | 28/06/2024 | 02/07/2024 | French | |
| Abridged model | 31/12/2022 | 02/06/2023 | 09/08/2023 | French | |
| Abridged model | 31/12/2021 | 03/06/2022 | 06/07/2022 | French | |
| Abridged model | 31/12/2020 | 04/06/2021 | 10/06/2021 | French | |
| Abridged model | 31/12/2019 | 16/05/2020 | 19/05/2020 | French | |
| Abridged model | 31/12/2018 | 07/06/2019 | 09/07/2019 | French | |
| Abridged model | 31/12/2017 | 28/08/2018 | 31/08/2018 | French | |
| Abridged model | 31/12/2016 | 02/06/2017 | 10/07/2017 | French | |
| Abridged model | 31/12/2015 | 06/04/2016 | 01/08/2016 | French | |
| Abridged model | 31/12/2014 | 08/06/2015 | 28/07/2015 | French | |
| Abridged model | 31/12/2013 | 06/06/2014 | 13/08/2014 | French | |
| Abridged model | 31/12/2012 | 07/06/2013 | 23/08/2013 | French | |
| Abridged model | 31/12/2011 | 01/06/2012 | 29/06/2012 | French | |
| Abridged model | 31/12/2010 | 03/06/2011 | 26/08/2011 | French | |
| Abridged model | 31/12/2009 | 04/06/2010 | 23/08/2010 | French | |
| Abridged model | 31/12/2008 | 05/06/2009 | 01/07/2009 | French | |
| Abridged model | 31/12/2007 | 06/06/2008 | 14/07/2008 | French | |
| Abridged model | 31/12/2006 | 01/06/2007 | 22/06/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 16 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates23/01/2026DEMISSIONS, NOMINATIONS
- Other16/06/2025OBJET
- Mandates02/05/2023MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Mandates01/08/2018DEMISSIONS, NOMINATIONS
- Other18/09/2017BENAMING
- Mandates18/09/2017DENOMINATION
- Other19/06/2017BENAMING - DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates19/06/2017DENOMINATION - OBJET - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025307,1 k €↑
- 2024Annual accounts 2024218 k €↓
- 2023Annual accounts 2023270 k €↓
- 2022Annual accounts 2022503 k €↑
- 2021Annual accounts 2021347,3 k €↑
- 2020Annual accounts 2020285,3 k €↑
- 2019Annual accounts 2019271,2 k €↑
- 2018Annual accounts 2018105 k €↓
- 2017Annual accounts 2017207,7 k €↑
- 2016Annual accounts 20164,5 k €↓
- 2016Name changeSHARK MEDICAL
- 2015Annual accounts 20158,1 k €↑
- 2014Annual accounts 20144,3 k €↑
- 2013Annual accounts 20133,7 k €↓
- 2012Annual accounts 20124,1 k €↑
- 2011Annual accounts 2011-557,2 €↓
- 2011Name changeICB
- 2010Annual accounts 20102,6 k €↑
- 2009Annual accounts 20091,5 k €↑
- 2008Annual accounts 20081 k €↓
- 2007Annual accounts 20072,1 k €↓
- 2006Annual accounts 20062,8 k €
- 2006Name changeINTERNATIONAL CONSULTING BELGIUM
- 28/01/1998IncorporationPrivate limited company